SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Oxford Biomedica, (OXB).
An SI Board Since June 2000
Posts SubjectMarks Bans
111 5 0
Emcee:  Oily1 Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
111The Oxford said: GenaTHERA lack credibility and bid withdrawn.. Here are some hmlkr-7/6/2009
110GENETERA taking over troubled OXFORD BIOMEDICAmlkr-9/4/2008
109OXFORD BIOMEDICA ANNOUNCES ENCOURAGING RESULTS FROM THREE PHASE II TRIALS OF Oily1-3/2/2005
108OXFORD BIOMEDICA AND VIRAGEN REPORT PROGRESS IN AVIAN TRANSGENICS BIOMANUFACTURIOily1-2/17/2005
107Termination of discussions On 19 January 2005 the Board of Oxford BioMedica annOily1-2/7/2005
106<B>OXFORD BIOMEDICA SIGNS LENTIVECTOR(R) LICENSING AGREEMENT</B> OxOily1-2/1/2005
105RNS Number:9779H Oxford Biomedica PLC 31 January 2005 Oxford BioMedica plc (theOily1-1/31/2005
104Oxford Biomedica PLC said it notes the recent movement in the company's shaOily1-1/19/2005
103<B><U>Notification of Major Interests in Shares.</B></U>Oily1-1/12/2005
102OXFORD BIOMEDICA SIGNS LENTIVECTOR(R) LICENSING AGREEMENT WITH BIOGEN IDEC OxfoOily1-1/5/2005
101OXFORD BIOMEDICA PUBLISHES PRECLINICAL EFFICACY RESULTS WITH ITS PRODUCT CANDIDAOily1-12/16/2004
100OXFORD BIOMEDICA LICENSES RETROVIRAL EX VIVO GENE DELIVERY TECHNOLOGY TO MOLMED Oily1-12/13/2004
99<u><b>Notification of Major Interests in Shares</u></b> Oily1-11/1/2004
98Oxford Biomedica Signs License Agreement with Massachusetts General Hospital &amOily1-10/21/2004
97Notification of Major Interests in Shares The Company has received a notificatiOily1-9/22/2004
96Oxford Biomedica PLC-License Agreement RNS Number:0542D Oxford Biomedica PLC 17Oily1-9/17/2004
95Oxford Biomedica in marketing talks on TroVax. By David Firn in London (FinanciOily1-9/2/2004
94Interim results :- oxfordbiomedica.co.ukOily1-9/1/2004
93"SUBSTANTIAL VALUE GENERATION THIS YEAR AND IN 2005" LONDON (AFX) - OOily1-9/1/2004
92Interim Results : Web Cast Notification Wednesday 1 September 2004 On behalf oOily1-8/24/2004
91Appointment of Broker RNS Number:0669C Oxford Biomedica PLC 18 August 2004 FOROily1-8/18/2004
90OXFORD BIOMEDICA LICENSES LENTIVECTOR TECHNOLOGY TO VIRAGEN FOR AVIAN TRANSGENICOily1-7/5/2004
89LENTIVECTOR(R) GENE DELIVERY SYSTEM RESULTS IN HIGH SUCCESS RATE IN AVIAN TRANSOily1-6/21/2004
88Acquisition :- Oxford Biomedica PLC said it has signed an agreement with ChironOily1-6/7/2004
87INNUREX(R) PRODUCT RESTORES LIMB FUNCTION RNS Number:2978Z Oxford Biomedica PLCOily1-6/2/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News